Oxygen Biotherapeutics, Inc. Issued U.S. Patent for Dermatologic Indications
Published: Sep 10, 2013
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced that the United States Patent and Trademark Office has issued the Company patent#8,513,309, titled, “Perfluorocarbons for use in Treating Pruritus.” This patent addresses methods for treating pruritus (itching), a sensation that a patient instinctually attempts to relieve by rubbing or scratching.
Help employers find you! Check out all the jobs and post your resume.